GENETIC TECH LIMITED has a total of 41 patent applications. It increased the IP activity by 1600.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, computer technology and pharmaceuticals are VERACYTE INC, CARDIODX INC and MULTIPLICOM NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 16 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 4 | |
#4 | Canada | 3 | |
#5 | Israel | 3 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | Brazil | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Pharmaceuticals | |
#4 | Medical technology | |
#5 | Organic fine chemistry | |
#6 | Measurement | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Allman Richard | 28 |
#2 | Dite Gillian | 9 |
#3 | Hopper John | 8 |
#4 | Vom Eduardo | 4 |
#5 | Mantzaris Debbie | 4 |
#6 | Cox David R | 4 |
#7 | Hinds David A | 3 |
#8 | Cantsilieris Stuart | 2 |
#9 | Walser Bryan | 2 |
#10 | Mccamish Mark A | 2 |
Publication | Filing date | Title |
---|---|---|
CA3078756A1 | Methods of assessing risk of developing breast cancer | |
CN110382712A | The improved method of risk for assessment development breast cancer | |
EP3201360A1 | Methods for assessing risk of developing breast cancer | |
AU2013245490A1 | Biological sampling device | |
AU2004217872A1 | Identification of fetal DNA and fetal cell markers in maternal plasma or serum | |
AU2003250619A1 | High resolution analysis of genetic variation within Cryptosporidium parvum | |
AU2003229397A1 | Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |